Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Davis

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Journal of Clinical Microbiology|April 1, 1982
Atypical biogroups of Escherichia coli found in clinical specimens and description of Escherichia hermannii sp. novD J Brenner, B R Davis, A G Steigerwalt, et al.
Circulation|July 1, 1996
Coronary heart disease risk factors in men and women aged 60 years and older: findings from the Systolic Hypertension in the Elderly ProgramP H Frost, B R Davis, A J Burlando, et al.
Circulation|November 15, 1996
Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP)P H Frost, B R Davis, A J Burlando, et al.
Journal of the American College of Cardiology|July 10, 1999
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE InvestigatorsG C Flaker, J W Warnica, F M Sacks, et al.
The New England Journal of Medicine|September 13, 1992
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsM A Pfeffer, E Braunwald, L A Moyé, et al.
Journal of Clinical Microbiology|January 1, 1985
Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimensJ J Farmer, G R Fanning, B R Davis, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
The Pharmacogenomics Journal|June 6, 2012
RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatmentA I Lynch, M R Irvin, E Boerwinkle, et al.
JAMA|July 25, 2000
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)H M Perry, B R Davis, T R Price, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1991
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and designN O Borhani, W B Applegate, J A Cutler, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Journal of Clinical Microbiology|April 1, 1982
Atypical biogroups of Escherichia coli found in clinical specimens and description of Escherichia hermannii sp. novD J Brenner, B R Davis, A G Steigerwalt, et al.
Circulation|July 1, 1996
Coronary heart disease risk factors in men and women aged 60 years and older: findings from the Systolic Hypertension in the Elderly ProgramP H Frost, B R Davis, A J Burlando, et al.
Circulation|November 15, 1996
Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP)P H Frost, B R Davis, A J Burlando, et al.
Journal of the American College of Cardiology|July 10, 1999
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE InvestigatorsG C Flaker, J W Warnica, F M Sacks, et al.
The New England Journal of Medicine|September 13, 1992
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsM A Pfeffer, E Braunwald, L A Moyé, et al.
Journal of Clinical Microbiology|January 1, 1985
Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimensJ J Farmer, G R Fanning, B R Davis, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
The Pharmacogenomics Journal|June 6, 2012
RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatmentA I Lynch, M R Irvin, E Boerwinkle, et al.
JAMA|July 25, 2000
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)H M Perry, B R Davis, T R Price, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1991
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and designN O Borhani, W B Applegate, J A Cutler, et al.
Pageof 18